Evidence map›Paper›PMID 29801494›Full record

ArticleHarm reduction journal2018

"Who has ever loved a drug addict? It's a lie. They think a 'teja' is as bad person": multiple stigmas faced by women who inject drugs in coastal Kenya.

Gitau Mburu, Sylvia Ayon, Alexander C Tsai, James Ndimbii, Bangyuan Wang, Steffanie Strathdee, Janet Seeley

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Harm reduction journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Helping Women Suffering from Drug Addiction: Needs, Barriers, and Challenges.International journal of environmental research and public health · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Gitau MburuDivision of Health Research, Lancaster University, Lancaster, UK. g.mburu@lancs.ac.uk.
Sylvia AyonKenya AIDS NGO Consortium, Nairobi, Kenya.
Alexander C TsaiChester M. Pierce, MD Division of Global Psychiatry, The Massachusetts General Hospital, Boston, USA.
James NdimbiiKenya AIDS NGO Consortium, Nairobi, Kenya.
Bangyuan WangInternational HIV/AIDS Alliance, Brighton, UK.
Steffanie StrathdeeDivision of Global Public Health, University of California San Diego School of Medicine, San Diego, USA.
Janet SeeleyDepartment of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK.
Kenya AIDS NGOs Consortium · KEInternational HIV/AIDS Alliance · GBLancaster University · GBLondon School of Hygiene & Tropical Medicine · GBMassachusetts General Hospital · USUniversity of California, San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA tenth of all people who inject drugs in Kenya are women, yet their social contexts and experiences remain poorly understood. This paper reports how multiple forms of stigma are experienced by women who inject drugs in coastal Kenya and the impact that they have on their ability to access essential health services.

methodsIn 2015, in-depth interviews and focus group discussions were held with 45 women who inject drugs in two coastal towns. These data were supplemented with in-depth interviews with five individual stakeholders involved in service provision to this population. Data were analyzed thematically using NVivo.

resultsWomen who inject drugs experience multiple stigmas, often simultaneously. These included the external stigma and self-stigma of injection drug use, external gender-related stigma of being a female injecting drug user, and the external stigma of being HIV positive (i.e., among those living with HIV). Stigma led to rejection, social exclusion, low self-esteem, and delay or denial of services at health facilities.

conclusionHIV and harm reduction programs should incorporate interventions that address different forms of stigma among women who inject drugs in coastal Kenya. Addressing stigma will require a combination of individual, social, and structural interventions, such as collective empowerment of injecting drug users, training of healthcare providers on issues and needs of women who inject drugs, peer accompaniment to health facilities, addressing wider social determinants of stigma and discrimination, and expansion of harm reduction interventions to change perceptions of communities towards women who inject drugs.

Indexed as

Social StigmaAdolescentAdultAttitude to HealthDrug UsersFemaleHarm ReductionHIV InfectionsHumansKenyaMiddle AgedPrejudiceSelf ConceptSubstance Abuse, IntravenousYoung AdultHarm reductionHIVInjecting drug useKenyaStigmaWomen who inject drugs

Identifiers

PMID29801494
PMCPMC5970466
OpenAlexW2805731080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.